Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative study [PDF]
, 2014 Jasvinder A. Singh
openalex +1 more source
Variation in Serum Urate Levels in the Absence of Gout and Urate Lowering Therapy: An Analysis Using Data from a Randomized Controlled Trial [PDF]
, 2020 Andrew Shaffer +4 more
openalex +1 more source
Combination of sodium-glucose cotransporter type 2 inhibitors and urate-lowering therapy in people with gout from a specialist clinic: a retrospective, single-center observational study. [PDF]
Front Med (Lausanne)Doménech-Serrano J +5 more
europepmc +1 more source
Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout. [PDF]
BMC Med Inform Decis Mak, 2022 Te Kampe R +8 more
europepmc +1 more source
Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients [PDF]
, 2017 Carly A. Janssen +4 more
openalex +1 more source
Firsekibart as a Prophylactic Treatment for Acute Gout Flare in Participants Initiating Urate-Lowering Therapy: A Phase 2, Randomized, Open-Label, Multicenter, Active-Controlled Trial. [PDF]
ACR Open RheumatolYu Y +14 more
europepmc +1 more source
Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout. [PDF]
Int J Med Sci, 2021 Yen FS +5 more
europepmc +1 more source
Identification of Febuxostat as a New Strong ABCG2 Inhibitor: Potential Applications and Risks in Clinical Situations [PDF]
, 2017 Hiroshi Miyata +5 more
core +1 more source
Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR) [PDF]
, 2013 Carlo Scirè +11 more
core +1 more source